Base de dados : HANSEN
Pesquisa : ANTIGENOS [Descritor de assunto]
Referências encontradas : 329 [refinar]
Mostrando: 1 .. 20   no formato [Detalhado]

página 1 de 17 ir para página                         

  1 / 329 HANSEN  
              next record last record
seleciona
para imprimir
Id:27300
Autor:Soebono, Haryanto; Giphart, Marius J; Schreuder, Geziena M. T; Klatser, Paul R; Vries, Rene R. P. de.
Título:Associations between HLA-DRB1 alleles and leprosy in an Indonesian population.
Fonte:Int. J. Lepr;65(2):190-196, Jun. 1997. tab.
Resumo:To investigate whether the susceptibility to leprosy (type), subclinical infection with Mycobacterium leprae and the antibody response against M. leprae-specific antigens are associated with HLA-DR phenotypes sequence-specific oligonucleotide HLA-DRB1 and DQA1 typing and antibody assays have been performed in 79 leprosy patients (41 TT/BT and 38 LL/BL) and 50 healthy controls from a Javanese population in Yogyakarta, Indonesia. DRB1*02 was associated with LL/BL [odds ratio (OR) 2.54, 95% confidence interval (CI) 0.97-9.78, p = 0.037 and attributable risk (AR) 41.5%] but not with TT/BT leprosy (p > 0.05). HLA-DRB1*12 was negatively associated with leprosy (either LL/BL or TT/BT [OR 0.33-0.35, p < 0.05, prevented fraction (PF) 58.8%-65.3%]. No significant association was found between HLA-DRB1 or DQA1 type, anti-M. leprae antibody level and subclinical infection with M. leprae. These data indicate that in this population susceptibility to lepromatous leprosy is associated with HLA-DRB1*02, while resistance to leprosy is associated with HLA-DRB1*12. These associations are not paralleled with associations of the same HLA types with anti-M. leprae antibody level. Finally, the results of this study also support the notion that infection with M. leprae per se is not associated with HLA-DRB1 or DQA1 alleles. (AU)^ien.
Descritores:Hanseníase Dimorfa/genet
Hanseníase Virchowiana/genet
Hanseníase Tuberculóide/genet
Antígenos HLA-DQ/genet
Antígenos HLA-DR/genet
Localização:BR191.1


  2 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:27135
Autor:Shu-Guang, Li; Vries, Rene RP.
Título:HLA DQ molecules may be products of an immune suppression gene responsible for Mycobacterium leprae specific nonresponsiveness.
Fonte:Int J Lepr;57(2):554-555, June 1989. ^bgraf, ^btab.
Descritores:Hanseníase Virchowiana/genet
Hanseníase Virchowiana/imunol
Antígenos HLA-DQ/genet
Antígenos HLA-DQ/imunol
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/1989/pdf/v57n2/v57n2cor01.pdf - en.
Localização:Br191.1


  3 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:27096
Autor:Vilalva, Fernanda Castro Jobim
Título:Determinação dos níveis séricos de MBL, dos anticorpos anti-PGL-I e dos alelos HLA de classe I e classe II em pacientes com hanseníase
Determination of MBL and anti-PGL-I serum levels and HLA ClassI and II in patients with leprosy-
Fonte:Bauru; s.n; 2010. 81 p. ilus, tab.
Resumo:A hanseníase é uma doença infecto-contagiosa e endêmica, constitui grave problema de saúde pública por causar incapacidade física permanente. A doença caracteriza-se por apresentar um amplo espectro de manifestações clínicas que correspondem a distintos padrões de resposta imunológica diante do mesmo agente etiológico, o Mycobacterium leprae. Métodos sorológicos têm sido desenvolvidos com a finalidade de auxiliar no diagnóstico precoce e estados reacionais, no monitoramento da eficácia da quimioterapia e no estudo da epidemiologia da hanseníase. Este estudo teve como objetivos: avaliar os níveis séricos de Lectina Ligada a Manose (MBL) e dos anticorpos anti-PGL-I em poacientes com hanseníase, em atividades, atendidos no Instituto Lauro de Souza Lima, SP, com ou sem o tratamento de poliquimioterapia e nos estados reacionais tipo 1 e 2; correlacionar os resultados dos nívceis séricos de MBL, e dos anticorpos anti-PGL-I com o índice baciloscópico (IB); avaliar a freqüência dos alelos HLA de classe I e II (locus A, B, DR e DQ) neste grupo de pacientes. Para a avaliação do anticorpo anti-PGL-I e da MBL foram estudados 69 pacientes sendo 21 do gênero feminino e 48 do gênero masculino, com idade variando de 11 a 72 anos. Quanto a classificação clínica, 12 eram tuberculóides (HT), 23 vichovianos (HV) e 34 dimorfos [18 dimorfos-tuberculóides (HDT), 09 dimorfos-dimorfos (HDD) e 07 dimorfos-virchovianos (HDV)]. Entre os pacientes avaliados, 38 apresentaram reações, sendo 20 reação tipo 1 e 18 reação tipo 2. Quanto ao esquema de tratamento, 43 pacientes eram multibacilares (MB) e 26 paucibacilares (PB). Neste estudo foram avaliados marcadores labaratoriais séricos MBL e anti-PGL-I pelo método imunoenzimático (ELISA) e os antígenos de histocompatibilidade pelo método Reverse Line blot. Os resultados dos níveis de anti-PGL-I forma mais altos nos pacientes MB comparados aos PB e mostraram uma forte associação com a carga bacilar. Com relação à MBL, nossos achados sugerem... (AU)^ipt.
Descritores:Hanseníase/quimioter
Anticorpos/imunol
Antígenos HLA/imunol
Lectinas/imunol
Localização:BR191.1; WC335.504, V71a


  4 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:27074
Autor:Wang, Li-Man; Kimura, Akinori; Satoh, Manatsu; Mineshita, Satoru.
Título:HLA linked with leprosy in Southern China; HLA-linked resistance alleles to leprosy.
Fonte:Int. J. Lepr;67(4):403-408, Dec., 1999. .
Resumo:According to the World Health Organization recommended multidrug therapy (WHO/MDT), we have carried out this study to investigate the presence of HLA-linked susceptibility or resistance to leprosy in a southern Chinese population. Sixty-nine leprosy patients and 112 healthy controls participated in the study. HLA-DR2 subtypes, HLA-B and MHC Class I chain-related A (MICA) alleles were typed at the DNA level using the polymerase chain reaction-single strand conformation polymorphism method. The frequencies of HLA-DR2-DRB1 alleles did not show any significant differences between the patient and the control groups, suggesting that the disease susceptibility was not associated with the DR2 subtypes in this southern Chinese population. On the other hand, in the multibacillary (MB) patients significantly decreased allele frequencies of HLA-B46 (0.040 in MB patients vs 0.129 in controls) and MICA-A5 (0.200 vs 0.380) were observed compared with the healthy controls. The calculated relative risk (RR) for B46 was 0.28; for MICA-A5, 0.52. In addition, on haplotype analysis the frequency of the HLA-B46/MICA-A5 haplotype was significantly decreased in the MB patients compared to controls (0.060 vs 0.233, RR = 0.22, p < 0.01). These results suggest that an HLA-linked disease-resistant gene to MB leprosy in southern China is in strong linkage disequilibrium with the HLA-B46/MICA-A5 haplotype. In other words, the resistant gene may be located near the HLA-B/MICA region and not in the HLA-DR locus. (AU)^ien.
Descritores:Antígenos HLA/anal
Antígenos HLA/imunol
Hanseníase/genet
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/1999/pdf/v67n4/v67n4a05.pdf - en.
Localização:BR191.1


  5 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:27030
Autor:Ngamying, Maeya; Levy, Louis; Brennan, Patrick J.
Título:Vaccination of mice against the leprosy bacillus with skin-test antigens.
Fonte:Int. J. Lepr;67(3):305-307, Sept., 1999. .
Descritores:Antígenos/uso diag
Antígenos/imunol
Mycobacterium leprae/genet
Mycobacterium leprae/imunol
Limites:Camundongos
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/1999/pdf/v67n3/v67n3cor02.pdf - en.
Localização:BR191.1


  6 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26990
Autor:Rojas-Espinosa, Oscar; Segura, Ruben Marroquin; Rodriguez, Kendy Wek; Reyes-Maldonado, Elba; Paredes, Patricia Arce.
Título:Susceptibility of "et," the spontaneously mutating CD-1 derived nude mouse, to infection of M. lepraemurium.
Fonte:Int. J. Lepr;67(1):46-51, Mar., 1999. ilus, graf.
Resumo:We have studied the susceptibility to infection by Mycobacterium lepraemurium (MLM) of a nude, hypothymic, CD1-derived, spontaneous mouse mutant called [quot ]et[quot ] because of its extraterrestrial appearance. We found that despite their hypothymia, et/et mice were not more susceptible to infection by MLM than their euthymic et/+ counterparts. Infection of both et/et and et/+ mice with 50 x 10(6) bacilli by the intraperitoneal route led only to a mild infection with low levels of antimycobacterial antibodies and a small number of lesions. These lesions were indicative of reactive hepatitis and hyaline perisplenitis with lymphoid hyperplasia. Some small bacilliferous granulomas were also observed at the end of the experiment (5 months of infection). CD1 mice behave in a rather [quot ]resistant[quot ] manner to the infection by MLM. It is clear that the nu gene is not necessarily linked to the thymus defect, and it is also clear that the hypothymia of et/et mice does not obviously affect their general cell-mediated immune competence. (AU)^ien.
Descritores:Mycobacterium lepraemurium/imunol
Mycobacterium lepraemurium/fisiol
Antígenos CD1/fisiol
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/1999/pdf/v67n1/v67n1a06.pdf - en.
Localização:BR191.1


  7 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26950
Autor:Lord, Rosanne; Naish, Caroline; Taylor, Clare; Stanford, Cynthia; Stanford, John L; Chacko, Chinoy JG; Debandu, Vivanathan; Samson, Prabhakar D; Berchmans, John; Surendran, Deeradaylu; Ramu, Gopal; Rees, Richard JW.
Título:Skin test studies on close contacts of leprosy patients in India.
Fonte:Int. J. Lep;57(4):801-809, dec. 1989. ^btab, ^bgraf.
Resumo:Skin-test studies with a series of tuberculins have been carried out in close contacts of multibacillary (MB) leprosy patients around three leprosy centers in India, and casual contacts of the disease around two centers. The results show that the rate of acquisition of leprosin A positivity is associated with age and the closeness of contact with MB leprosy. At the age of 15 years, the differences between the two types of contact were highly significant (p less than 0.00001). Many responses to leprosin A are directed toward the group iv species-specific, antigens of the leprosy bacillus, and the significance of positivity is discussed in relation to protective immunity from leprosy. The differences from Iran show that positivity to leprosin A is not solely the effect of the degree of contact with the disease, but must also have a genetic or environmental element, the latter being favored. The results from Miraj show that the high levels of tuberculin, scrofulin, and vaccin positivity seen in Fathimanagar, and to a lesser extent in Karigiri, are not a consequence of contact with leprosy. BCG vaccination made little difference to the leprosin A positivity of close contacts of leprosy patients, although it significantly enhanced positivity among casual contacts around Miraj (p less than 0.002). BCG vaccination significantly increased tuberculin positivity in Miraj and Karigri, and in those under 11 years of age in Fathimanagar. It made no difference to the already high level of positivity found in older persons around Fathimanagar.
Descritores:Antígenos de Bactérias/imunol
Vacina BCG/imunol
Hanseníase/epidemiol
Hanseníase/transm
Índia/epidemiol
Limites:Humanos
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/1989/pdf/v57n4/v57n4a08.pdf - en.
Localização:Br191.1


  8 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26948
Autor:Mutis, Tuna; Van Schoote, Wim CA; Vries, René RP.
Título:A peptidoglycan protein complex purified from M Leprae cell walls contains most or all immunodominat M leprae T-cell antigens.
Fonte:Int. J. Lep;57(4):788-793, dec. 1989. .
Resumo:The outcome of an infection with Mycobacterium leprae is correlated with the T-cell-mediated immune response developed against this pathogenic agent. The identification of M. leprae antigens that are recognized by T cells is therefore of great importance. In this paper we present the results of in vitro lymphoproliferation assays in which T-cell reactivity was measured against a peptidoglycan-protein complex (PPC) which was purified from the cell wall of M. leprae. Twelve M. leprae-reactive T-cell clones with different antigen specificities from a tuberculoid (TT) leprosy patient showed proliferative responses, but only when PPC was presented by HLA-DR-matched antigen-presenting cells (APCs). Four of these clones were known to react with the recombinant mycobacterial 65-kDa protein. A tetanus-toxoid-reactive T-cell line from a healthy control was not stimulated by this complex, supporting the idea that the stimulation by PPC was antigen specific. Both PPD-reactive and M. leprae-reactive T-cell lines from healthy individuals were stimulated by PPC. However, when this complex was presented to PPD-reactive T-cell lines derived from two lepromatous (LL) leprosy patients, we did not observe any proliferative responses. From these results we conclude that PPC contains most or all of the antigens which stimulate M. leprae-reactive T cells in association with relevant HLA class II molecules, including the 65-kDa protein or at least some immunogenic parts of it.
Descritores:Antígenos de Bactérias/imunol
Parede Celular/fisiol
Mycobacterium leprae/imunol
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/1989/pdf/v57n4/v57n4a06.pdf - en.
Localização:Br191.1


  9 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26947
Autor:Mullins, raymond J; Basten, Antony.
Título:Effect pf preincubation on the proliferative response to antigen by cells from leprosy patients and healthy controls.
Fonte:Int. J. Lep;57(4):777-787, dec. 1989. ^btab, ^bgraf.
Resumo:One of the postulated mechanisms contributing to the selective T-cell hyporesponsiveness in patients with leprosy is receptor blockade, the characteristic feature of which is reversibility following preincubation of cells in vitro. To test this hypothesis, peripheral blood mononuclear cells (PBMC) obtained from 17 leprosy patients and 10 healthy Mantoux-positive and -negative controls were cultured freshly or after a period of preincubation in serum-containing medium, and the proliferative responses to Mycobacterium leprae, BCG, and streptokinase-streptodornase (SKSD) were measured. On the basis of the response to M. leprae, the leprosy patients could be divided into low, intermediate and high responders. Preincubation for 2-16 hr resulted in enhanced proliferation by cells from moderate responders, but not from low or high responders. Although the effect was serum dependent, it was neither antigen specific nor was it confined to cells from leprosy patients. Thus, an increase in response to both the crossreactive and unrelated antigens BCG and SKSD occurred, and the same trend was observed when cells from healthy controls were preincubated in serum-containing medium. Furthermore, cells from different individuals displayed varying responses to different antigens following preincubation, suggesting that the effect of this step was neither confined to isolated individuals nor to particular antigens. The addition of pronase to the preincubation step did not further enhance the response to antigen over and above that obtained with preincubation alone. It was therefore concluded that the enhanced proliferative response to antigen following preincubation was an in vitro phenomenon dependent upon the culture conditions employed, was not specific to leprosy, and was not related to receptor blockade.
Descritores:Antígenos de Bactérias/imunol
Fenômenos Fisiológicos Sanguíneos
Mycobacterium bovis/imunol
Mycobacterium leprae/imunol
Limites:Humanos
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/1989/pdf/v57n4/v57n4a05.pdf - en.
Localização:Br191.1


  10 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26944
Autor:Gelber, Robert H; Li, Futian; Cho, SN; Byrd, Sally; Rajagopalan, K; Brennan, Patrick J.
Título:Serum antibodies to defined carbohydrate antigens during the course of treated leprosy.
Fonte:Int. J. Lep;57(4):744-751, dec. 1989. .
Resumo:Sequential monitoring of 724 sera for antibodies to a neoantigen based on phenolic glycolipid-I (PGL-I) and native lipoarabinomannan (LAM) in 90 leprosy patients undergoing therapy in San Francisco was conducted. Untreated lepromatous patients frequently (91%) had significant antibodies to both moieties. Antibodies were less frequently found in tuberculoid patients (74% to neoantigen and 37% to LAM). In the first 3 years of treatment, average serum antibodies to both moieties fell significantly. Antibodies to LAM fell during each of the first 4 years of therapy, but decreasing antibody levels to the PGL-I neoantigen did not appear to fall consistently after the third year of treatment. A wide variation in the rate of fall of serum antibodies was noted. Sequential changes in the amounts of serum antibodies to the neoantigen and LAM in general paralleled one another but were at times discrepant. Both in San Francisco and Malaysia, skin-smear negative, long-term treated, lepromatous leprosy patients frequently harbored significant antibodies to both PGL-I and LAM.
Descritores:Anticorpos Antibacterianos/imunol
Anticorpos Antibacterianos/fisiol
Antígenos de Bactérias/imunol
Glicolipídeos/imunol
Hanseníase/terap
Limites:Humanos
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/1989/pdf/v57n4/v57n4a02.pdf - en.
Localização:Br191.1


  11 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26943
Autor:Chanteau, Suzanne; Cartel, Jean-Louis; Celerier, Philippe; Plichart, Régis; Desforges, Sylvie; Roux, Jean.
Título:PGL-1 antigen and antibody detection in leprosy patients: evolution under chemotherapy.
Fonte:Int. J. Lep;57(4):735-743, dec. 1989. ^btab.
Resumo:Multibacillary (MB) and paucibacillary (PB) leprosy patients were tested for circulating phenolic glycolipid-I (PGL-I) antigen and antibodies before treatment. In the 27 MB patients tested, 27 (100%) were antigen positive with levels ranging from 50 to 5000 ng/ml, and 26 (96%) were antibody positive with titers ranging from 1000 to 64,000. Although the antigen and antibody levels were much higher in MB than in PB patients, we could not demonstrate a correlation between the number of acid-fast bacilli/mg of skin biopsy and these two parameters in 14 MB patients. After starting daily multidrug therapy, 10 MB patients were monitored monthly. As much as 88.75% +/- 10.8% of the PGL-I antigen was cleared from the bloodstream after 1 month while the anti-PGL-I antibody remained stable. This rapid decrease in the PGL-I antigen level strongly suggests the usefulness of this test for monitoring MB patients under chemotherapy.
Descritores:Anticorpos Antibacterianos/anal
Antígenos de Bactérias/anal
Dapsona/uso terap
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/1989/pdf/v57n4/v57n4a01.pdf - en.
Localização:Br191.1


  12 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26895
Autor:Joko, Satoru; Numaga, Jiro; Kawashima, Hidetoshi; Namisato, Masako; Maeda, Hiroo.
Título:Human leukocyte antigens in forms of leprosy among japanese patients.
Fonte:Int. J. Lepr;68(1):49-56, Mar., 2000. tab.
Resumo:Human leukocyte antigens (HLA) class II alleles were analyzed among Japanese leprosy patients to ascertain whether immunogenetic differences exist among the leprosy classification forms of Ridley and Jopling. Ninety-three unrelated Japanese leprosy patients (21 lepromatous, 24 borderline lepromatous, 17 mid-borderline, 26 borderline tuberculoid, 5 tuberculoid) and 114 healthy control subjects were investigated. The frequencies of HLA-DRB1*1501, -DRB5*0101, -DQA1*0102 and DQB1*0602 were significantly increased in all of the Japanese leprosy patients. The frequencies of HLA-DRB1*0405, -DQA1*03 and -DQB1*0401 were significantly decreased in the Japanese patients after correction of the p value. Conversely, there were no significantly different distributions of the HLA-DRB1, -DRB5, -DQA1, DQB1 alleles in the five subgroups of these patients. We conclude that HLA class II alleles were not associated with the form of leprosy. Other HLA, a non-HLA gene, and/or environmental factors may play a critical role in the different manifestations of leprosy.. (AU)^ien.
Descritores:Antígenos HLA/imunol
Antígenos HLA/fisiol
Hanseníase/imunol
Hanseníase/fisiopatol
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/2000/pdf/v68n1/v68n1a07.pdf - en.
Localização:BR191.1


  13 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26662
Autor:Huizar-López, Rosario; Santerre, Ann; Madrid-Marina, Vicente; Peralta-Zaragoza, Oscar; Villalobos-Arámbula, Alma; Islas-Rodríguez, Alfonso.
Título:AP-1 Is present in nuclear extracts of lymphocytes from lepromatous leprosy patients.
Fonte:Int. J. Lepr;70(4):274-277, Dec., 2002. ilus, tab.
Descritores:Hanseníase Virchowiana/imunol
Hanseníase Virchowiana/fisiopatol
Antígenos CD95/genet
Antígenos CD95/imunol
Linfócitos/imunol
Linfócitos/fisiol
Limites:Humanos
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/2002/pdf/v70n4/v70n4cor.pdf - en.
Localização:BR191.1


  14 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-en
Id:26610
Autor:Latif, Amany M. Abdel; Essa, Eman A.
Título:Study of HLA-DR expression on skin lesions of leprosy before and during multiple drug therapy.
Fonte:Int. J. Lepr;70(2):104-110, Jun. 2002. ilus, tab.
Resumo:Leprosy is a dynamic disease in which cell mediated immunity (CMI) plays an important role in host defense and control of the clinical spectrum. This study was carried out to detect immune activation in the granuloma of leprosy during multiple drug therapy (MDT) by studying the expression of human leukocytic antigen-DR (HLA-DR) in the granuloma before and during therapy. Skin punch biopsies were taken before and at least once 2-4 weeks after starting MDT in 20 newly diagnosed patients. Two biopsies, 2-4 weeks apart, were also taken from 10 new patients who did not yet receive any treatment, for comparison. Furthermore, biopsies were taken before and during corticosteroid therapy in five patients who developed reversal reaction during MDT. The biopsy specimens were studied for the expression of HLA-DR using the immunofluorescent staining which was found to be visibly increased in 17 out of 20 new cases (85%) within 2-4 weeks after starting MDT, while no change in the expression was noticed in those who did not receive any treatment (p < 0.001). This might reflect the increased production of interferon gamma (IFN gamma) specially from granuloma lymphocytes after being stimulated with the excessive release of mycobacterial antigen from killed bacilli during therapy. The five patients who developed reversal reaction during MDT had strong HLA-DR expression in the first biopsies which declined subsequently 2-6 weeks after starting prednisolone therapy. Our results suggest that CMI was activated in skin lesions of leprosy during MDT. Such activation was not only restricted to those who developed reversal reaction across the therapeutic course, which indicates that the difference between patients who developed such reaction and those who did not, was likely to be quantitative rather than qualitative, with a more exaggerated CMI response in the former. Furthermore, it seems that the beneficial effect of MDT is accompanied by important changes in the immune cell profile which have a great role in overcoming such infection.(AU)^ien.
Descritores:Antígenos HLA/imunol
Hanseníase/genet
Hanseníase/imunol
Hanseníase/fisiopatol
Hanseníase/terap
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/intjlepr/2002/pdf/v70n2/v70n2a02.pdf - en.
Localização:BR191.1


  15 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-pt
Id:26101
Autor:Almeida, José Oliveira de.
Título:Preparo, padronizado e comparação de antígenos em reações quantitativas de fixação de complemento com soros de doentes de lepra.
Fonte:Rev. bras. Leprol;26(3/4):181-271, jul.-dez. 1958. ^btab, ^bgraf.
Resumo:A reação de fixação do complemento em sôro de lepra com antígenos preparados de bacilos da tuberculose se deve à atividade haptênica dos fosfatídeos  ácidos complexos ligados a carboidratos e solúveis em piridina. O efeito anticomplementar dos ant¡genos solúveis em piridina ‚ corrigido pela lecitina; efeito semelhante se observa nos antígenos aquosos do bacilo da tuberculose. As reações entre antígeno, anticorpo e complemento, podem ser melhor estudadas por meio das "curvas de isofixação" obtidas por projeção de antígeno contra sôro, o complemento sendo mantido constante. A curva de isofixação em seu ramo vertical permite determinar as condições necessárias para a titulagem de antígenos e também a influência da quantidade de sôro presente na reação sôbre os parâmetros de linha de regressão: antígeno-complemento. O ramo horizontal da curva de isofixação indica as condições nas quais se deve processar a titulagem do sôro. A influência da dose de antígeno empregada sôbre os parâmetros da linha de regressão sôro-complemento pôde ser apreciada e dada uma correta interpretação. A dose de antígeno a ser usada numa titulagem de sôro é aquela que não afeta o relativo paralelismo das curvas de isofixação. Então, complemento fixado ser  função linear da quantidade de sôro presente. A parte da curva de isofixação que liga os dois ramos assintóticos, traduz a suplência observada entre sôro e antìgeno e indica as condições em que a fixação do complemento depende tanto da quantidade de sôro presente, como da quantidade de antígeno usado. Nesse caso, a titulagem de qualquer um dêsses elementos nâo poder  ser feita. Para a titulagem de sôros, por método simplificado, fatôres de conversão são utilizados. Êsses fatores foram determinados para o sistema lepra onde os valores de h sofrem marcada influência da quantidade de complemento necessário para 50% de hemólise, pois há  estreita dependência entre a percentagem de complemento fixado e a...(AU)^ipt.
Descritores:Hanseníase/genet
Hanseníase/imunol
Antígenos/genet
Antígenos/imunol
Tuberculose/genet
Tuberculose/imunol
Limites:Humanos
Masculino
Feminino
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/brasleprol/1958/PDF/v26n3-4/v26n3-4a06.pdf - pt.
Localização:BR191.1


  16 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-pt
Id:25955
Autor:Beiguelman, Bernardo.
Título:Grupos sangüíneos e lepra.
Fonte:Rev. bras. Leprol;31(1/2):34-44, jan.-jun. 1963. ^btab, ^bgraf.
Resumo:1- No presente trabalho o autor analisou a distribuição dos grupos sangu¡neos do sistema clássico ABO e Rh(D-d), num grupo de 1.127 doentes de lepra (1.656 lepromatosos e 471 tuberculóides), classificados de acordo com o tronco (stock) racial (tabela 1). 2- Quando a amostra é considerada como um todo, a frequencia do grupo sangu¡neo O nos doentes da forma tuberculóide mostra um excesso significante em relação à encontrada nos lepromatosos (tabela 2). 3- A amostra de doentes de lepra lepromatosa, quando comparada aos dados da população não leprosa, não apresenta diferença quanto à frequencia do grupo O. O mesmo não acontece com os tuberculóides, que apresentam um excesso de indiv¡duos desse grupo sanguineo. 4- Todas as sub-amostras consideradas mostraram estar em equil¡brio de Hardy-Weinberg (tabela 3), o que significa não ser a seleção do grupo O tão eficiente, a ponto de destruir o equil¡brio genético. 5- As sub-amostras lepromatosas e tuberculóides, comparadas quanto às estimativas das frequencias gênicas do sistema ABO, não mostraram diferenças significantes (tabela 3). Essa diferença, entretanto, aparece quando as amostras aumentam de tamanho. 6- Não se assinalaram diferenças na frequencia de Rh negativos entre lepromatosos e tubercul¢ides (tabela 1). 7- Sabendo-se que existem indicações recentes de que os ant¡genos de certos organismos infecciosos são serológicamente semelhantes aos ant¡genos do sangue, parece interessante averiguar se não seria este também o caso do Mycobacterium leprae. (AU)^ipt.
Descritores:Antígenos de Grupos Sanguíneos/anal
Antígenos de Grupos Sanguíneos/sangue
Antígenos de Grupos Sanguíneos/fisiol
Hanseníase/compl
Hanseníase/diag
Hanseníase/fisiopatol
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/brasleprol/1963/PDF/v31n1-2/v31n1-2a02.pdf - pt.
Localização:BR191.1


  17 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo
Id:25430
Autor:Silva, Sonia Maria Uso Ruiz; Carvalho, Claudia Peres Monteiro; Marcos, Elaine Valim Camarinha; Souza, Fabiana Covolo de; Ura, Somei; Almeida, Ricardo Augusto Monteiro de Barros.
Título:Identificação dos alelos HLA de classe I e classe II em pacientes co-infectados com hanseniase e aids / Identification of HLA alleles clas I and class II in co-infected patients with leprosy and aids
Fonte:Hansen. int;31(2):29-34, 2006. tab.
Resumo:O complexo HLA tem sido amplamente estudado, na tentativa de elucidar os mecanismos que levam ao direcionamento da forma clínica na hanseníase. Foram observadas associações positivas dos alelos HLA-DR2 e HLA-DR3, com a forma tuberculóide (HT) e do alelo HLA-DQ1, com a forma virchoviana (HV). Em relação ao HIV os alelos de classe I, HLA-B35 e HLA-Cw4 parecem estar mais fortemente associados com a deterioração imunológica e com a aceleração da progressão para a aids e os alelos HLA-A1, HLA-B8, HLA-B27, HLA-Cw7 e os de classe II, HLA-DR3 e HLA-DQ2 com a progressão lenta da doença. Por não haver nenhum dado na literatura descrevendo a participação dos alelos HLA em indivíduos co-infectados com hanseníase e HIV, o presente estudo teve como objetivo avaliar a freqüência dos alelos HLA de Classe I e II (locus A, B, C, DR e DQ) em pacientes co-infectados, atendidos no Instituto Lauro de Souza Lima de Bauru. Foi possível observar que a presença de alelos descritos na literatura como associados com rápida progressão da aids parece não influenciar no espectro clínico da hanseníase. Embora a infecção pelo HIV cause profundos danos no sistema imune, não houve direcionamento para a forma virchoviana multibacilar como se poderia esperar. Estudos abrangendo maior casuística devem ser conduzidos para que os resultados sejam mais informativos uma vez que a co-infecção HIV/M.leprae é um evento importante em área endêmica para ambas as doenças. (AU).
Descritores:HANSENIASE/diag
HANSENIASE/imunol
HANSENIASE/fisiopatol
ANTIGENOS HLA/quim
ANTIGENOS HLA/uso diag
ANTIGENOS HLA/imunol
SINDROME DE IMUNODEFICIÊNCIA ADQUIRIDA/imunol
Limites:ESTUDO COMPARATIVO
Meio Eletrônico: - http://www.ilsl.br/revista/index.php/hi/article/viewFile/82/63.
Localização:BR191.1


  18 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:25255
Autor:Reinherz, Ellis L; Schlossman, Stuart F
Título:The differentiation and function of human T lymphocytes
..-
Fonte:s.l; s.n; 1980. 7 p. tab, graf.
Descritores:ANTIGENOS DE DIFERENCIACAO DE LINFOCITOS B/anal
ANTIGENOS DE DIFERENCIACAO DE LINFOCITOS B/sangue
ANTIGENOS DE DIFERENCIACAO DE LINFOCITOS B/imunol
ANTIGENOS DE DIFERENCIACAO DE LINFOCITOS T/anal
ANTIGENOS DE DIFERENCIACAO DE LINFOCITOS T/sangue
ANTIGENOS DE DIFERENCIACAO DE LINFOCITOS T/imunol
ANTIGENOS SECUNDARIOS DE ESTIMULACAO DE LINFOCITOS/anal
ANTIGENOS SECUNDARIOS DE ESTIMULACAO DE LINFOCITOS/sangue
ANTIGENOS SECUNDARIOS DE ESTIMULACAO DE LINFOCITOS/imunol
LINFOCITOS/sangue
LINFOCITOS/clas
LINFOCITOS/imunol
INTERLEUCINA-1/anal
 INTERLEUCINA-1/sangue
 INTERLEUCINA-1/imunol
 ANTICORPOS MONOCLONAIS/bios
 ANTICORPOS MONOCLONAIS/isol
 ANTICORPOS MONOCLONAIS/farmacocin
 IMUNOFLUORESCÊNCIA/util
Limites:HUMANO
ANIMAL
Localização:BR191.1; 00799/s


  19 / 329 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:25233
Autor:Coock, J. V
Título:Complement fixation in leprosy
..-
Fonte:s.l; s.n; s.d. 19 p. tab.
Resumo:Leper serums contain complement-binding substances that react with antigens of acid-fast bacilli and give an acid-fast fixation similar to taht obtained with serums of rabbits immunized with acid-fast organisms. Some serums contain these antibodies in rather high concentration, notably those from cases with the nodular type of the disease; other serums show a relatively low antibody content. The serums of high titer may give a nonspecific fixation also with non-acid-fast antigens and with lipoidal (Wassermann) antigen, but only in comparatively low dilutions. It is suggested that this attribute of such high titer leper serums may explain a certain percentage of positive Wassermann reactions described in leprosy. Among the acid-fast antigens studied, certain organisms have superior antigenic properties in complement-fixation tests with leper serums. The acid-fast reaction given by leper serums with acid-fast bacterial antigens prevents the use of the complement-fixation reaction in obtaining evidence of the etiologic importance of any acid-fast organism isolated from leprosy. (AU).
Descritores:HANSENIASE/genet
HANSENIASE/microbiol
HANSENIASE/patol
ANTIGENOS/genet
ANTIGENOS/fisiol
Limites:ESTUDO COMPARATIVO
Localização:BR191.1; 03835/s


  20 / 329 HANSEN  
              first record previous record
seleciona
para imprimir
Id:25193
Autor:Visentainer, J. E. L; Tsuneto, L. T; Serra, M. F; Peixoto, P. R. F; Petzl-Erler, M. L
Título:Association of leprosy with HLA-DR2 in a Southern Brazilian population
..-
Fonte:s.l; s.n; 1997. 9 p. tab.
Resumo:The association between HLA specificities and lweprosy was investigated in a Southern Brazilian population. One hundred and twenty-one patients and 147 controls were typed for HLA-A, B, Cw, DR and DQ. Patients were subdivided into the following subgroups, according to clinical, histological and immunological criteria: lepromatous (N=55), tuberculoid (N=32), dimorphous (N=20), and indeterminate (N=14). The frequencies of HLA specificities were compared between the total group of patients and controls, and between the same controls and each subgroup of patients. After correction of the probabilities, deviations were not significant, except for the DR2 specificity, which presented a frequency of 44.2% in the total group of patients and 56.3% in the subgroup of invididuals with the tuberculoid from of the disease, compared to 23.3% in the controls. Stratified analysis showed that the increased DR2 frequency in the total group of patients was due to the subgroups with the tuberculoid and dimorphus forms. The relative risk of tuberculoid leprosy for DR2-positive individuals was 4.2 and etiologic fraction of DR2 was 0,429. In conclusion, a positive association of the DR2 specificity with the tuberculoid form of leprosy, but not with the lepromatous, dimorphous, or indeterminate forms, was demonstrated in this Southern Brazilian population (AU).
Descritores:HANSENIASE DIMORFA/imunol
HANSENIASE VIRCHOWIANA/imunol
HANSENIASE TUBERCULOIDE/imunol
ANTIGENOS DE HISTOCOMPATIBILIDADE/sangue
ANTIGENOS DE HISTOCOMPATIBILIDADE/imunol
HANSENIASE/imunol
Limites:HUMANO
Localização:BR191.1; 09275/s



página 1 de 17 ir para página                         
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information